Published in Exp Cell Res on March 01, 1990
Growth factor-induced delayed early response genes. Mol Cell Biol (1992) 3.03
Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells. Mol Cell Biol (2001) 2.72
SAR-dependent mobilization of histone H1 by HMG-I/Y in vitro: HMG-I/Y is enriched in H1-depleted chromatin. EMBO J (1993) 2.27
HMGI(Y) and Sp1 in addition to NF-kappa B regulate transcription of the MGSA/GRO alpha gene. Nucleic Acids Res (1995) 1.74
Functional interaction between the POU domain protein Tst-1/Oct-6 and the high-mobility-group protein HMG-I/Y. Mol Cell Biol (1995) 1.65
Organization, inducible-expression and chromosome localization of the human HMG-I(Y) nonhistone protein gene. Nucleic Acids Res (1993) 1.61
A poly(dA-dT) upstream activating sequence binds high-mobility group I protein and contributes to lymphotoxin (tumor necrosis factor-beta) gene regulation. Mol Cell Biol (1992) 1.61
Protein phosphatase 2A1 is the major enzyme in vertebrate cell extracts that dephosphorylates several physiological substrates for cyclin-dependent protein kinases. Mol Biol Cell (1993) 1.53
Isolation and characterization of maize cDNAs encoding a high mobility group protein displaying a HMG-box. Nucleic Acids Res (1991) 1.38
Phosphorylation of the DNA-binding domain of nonhistone high-mobility group I protein by cdc2 kinase: reduction of binding affinity. Proc Natl Acad Sci U S A (1991) 1.24
Scaffold attachment regions stimulate HSP70.1 expression in mouse preimplantation embryos but not in differentiated tissues. Mol Cell Biol (1994) 0.99
Construction and analysis of cells lacking the HMGA gene family. Nucleic Acids Res (2003) 0.92
HMGI(Y) activation by chromosome 6p21 rearrangements in multilineage mesenchymal cells from pulmonary hamartoma. Am J Pathol (1997) 0.91
Derepression of HMGA2 via removal of ZBRK1/BRCA1/CtIP complex enhances mammary tumorigenesis. J Biol Chem (2009) 0.87
Polyetheylenimine-polyplexes of Spiegelmer NOX-A50 directed against intracellular high mobility group protein A1 (HMGA1) reduce tumor growth in vivo. J Biol Chem (2010) 0.86
Repression of gonadotropin-releasing hormone promoter activity by the POU homeodomain transcription factor SCIP/Oct-6/Tst-1: a regulatory mechanism of phenotype expression? Mol Cell Biol (1997) 0.82
High mobility group proteins cHMG1a, cHMG1b, and cHMGI are distinctly distributed in chromosomes and differentially expressed during ecdysone dependent cell differentiation. Chromosoma (1997) 0.81
Replication-dependent and independent regulation of HMG expression during the cell cycle and conjugation in Tetrahymena. Nucleic Acids Res (1992) 0.76
Genome cross-referencing and XREFdb: implications for the identification and analysis of genes mutated in human disease. Nat Genet (1997) 10.14
Intrinsically disordered protein. J Mol Graph Model (2001) 8.54
Expression of recombinant plasmids in mammalian cells is enhanced by sodium butyrate. Nucleic Acids Res (1983) 5.61
High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol (1996) 4.22
Sodium butyrate inhibits histone deacetylation in cultured cells. Cell (1978) 4.20
The solution structure of an HMG-I(Y)-DNA complex defines a new architectural minor groove binding motif. Nat Struct Biol (1997) 2.56
Transcriptionally active chromatin. Biochim Biophys Acta (1984) 2.39
Comparative genomics, genome cross-referencing and XREFdb. Trends Genet (1995) 2.35
Complete murine cDNA sequence, genomic structure, and tissue expression of the high mobility group protein HMG-I(Y). J Biol Chem (1988) 2.30
Intravascular extraction of problematic or infected permanent pacemaker leads: 1994-1996. U.S. Extraction Database, MED Institute. Pacing Clin Electrophysiol (1999) 2.24
Minichromosome assembly of non-integrated plasmid DNA transfected into mammalian cells. Nucleic Acids Res (1985) 2.20
Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y. Mol Cell Biol (1989) 2.07
The influence of DNA and nucleosome structure on integration events directed by HIV integrase. J Biol Chem (1994) 2.03
Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter. Nucleic Acids Res (1993) 1.80
Evidence for a shared structural role for HMG1 and linker histones B4 and H1 in organizing chromatin. EMBO J (1996) 1.78
Posttranscriptional gene regulation and specific binding of the nonhistone protein HMG-I by the 3' untranslated region of bovine interleukin 2 cDNA. Proc Natl Acad Sci U S A (1987) 1.77
HMG protein family members stimulate human immunodeficiency virus type 1 and avian sarcoma virus concerted DNA integration in vitro. J Virol (1999) 1.71
Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin. Nat Genet (2000) 1.71
Headache in mild-to-moderate hypertension and its reduction by irbesartan therapy. Arch Intern Med (2000) 1.68
Conserved chromosomal positions of dual domains of the ets protooncogene in cats, mice, and humans. Proc Natl Acad Sci U S A (1986) 1.67
The DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences. Mol Cell Biol (1994) 1.65
Organization, inducible-expression and chromosome localization of the human HMG-I(Y) nonhistone protein gene. Nucleic Acids Res (1993) 1.61
A poly(dA-dT) upstream activating sequence binds high-mobility group I protein and contributes to lymphotoxin (tumor necrosis factor-beta) gene regulation. Mol Cell Biol (1992) 1.61
Gene elav of Drosophila melanogaster: a prototype for neuronal-specific RNA binding protein gene family that is conserved in flies and humans. J Neurobiol (1993) 1.57
Impact of age and gender on blood pressure and low-density lipoprotein cholesterol reduction: results of a pooled analysis. Curr Med Res Opin (2012) 1.39
Phosphorylation by cdc2 kinase modulates DNA binding activity of high mobility group I nonhistone chromatin protein. J Biol Chem (1991) 1.39
High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters. Immunity (1996) 1.37
High-mobility group protein HMG-I localizes to G/Q- and C-bands of human and mouse chromosomes. J Cell Biol (1989) 1.36
Pim-1 protein expression is regulated by its 5'-untranslated region and translation initiation factor elF-4E. Cell Growth Differ (1997) 1.29
Molecular cloning of a functional bovine interleukin 2 cDNA. Proc Natl Acad Sci U S A (1986) 1.29
Purification and postsynthetic modifications of Friend erythroleukemic cell high mobility group protein HMG-I. Anal Biochem (1986) 1.25
A rapid, reliable method of evaluating growth and viability of intraerythrocytic protozoan hemoparasites using fluorescence flow cytometry. Mem Inst Oswaldo Cruz (1992) 1.23
Butyrate suppression of position-effect variegation in Drosophila melanogaster. Mol Gen Genet (1980) 1.21
Sodium butyrate stimulates DNA repair in UV-irradiated normal and xeroderma pigmentosum human fibroblasts. J Biol Chem (1982) 1.20
Changes in superhelicity are introduced into closed circular DNA by binding of high mobility group protein I/Y. J Biol Chem (1995) 1.19
Specific A . T DNA sequence binding of RP-HPLC purified HMG-I. Biochem Biophys Res Commun (1987) 1.19
FR900482 class of anti-tumor drugs cross-links oncoprotein HMG I/Y to DNA in vivo. Chem Biol (2000) 1.16
PIM1 phosphorylates and negatively regulates ASK1-mediated apoptosis. Oncogene (2009) 1.15
Identification of a monoclonal antibody reactive with the bovine orthologue of CD3 (BoCD3). Vet Immunol Immunopathol (1993) 1.15
Sodium butyrate induces new gene expression in Friend erythroleukemic cells. J Biol Chem (1979) 1.14
Elevated high mobility group-I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells. Cancer Res (1993) 1.12
Chromatin remodeling of the interleukin-2 gene: distinct alterations in the proximal versus distal enhancer regions. Nucleic Acids Res (1998) 1.12
Competition between HMG-I(Y), HMG-1 and histone H1 on four-way junction DNA. Nucleic Acids Res (1997) 1.10
Association of cartilage defects, and other MRI findings with pain and function in individuals with mild-moderate radiographic hip osteoarthritis and controls. Osteoarthritis Cartilage (2013) 1.07
A conformational study of the sequence specific binding of HMG-I (Y) with the bovine interleukin-2 cDNA. Biochem Int (1988) 1.07
Analysis of monoclonal antibodies specific for the gamma delta TcR. Vet Immunol Immunopathol (1996) 1.07
Recombinant human pim-1 protein exhibits serine/threonine kinase activity. J Biol Chem (1991) 1.06
The role of high-mobility group I(Y) proteins in expression of IL-2 and T cell proliferation. J Immunol (2000) 1.05
Genomic transcriptional activity and the structure of chromatin. Nature (1976) 1.04
Ribosomal genes of Xenopus laevis: evidence of nucleosomes in transcriptionally active chromatin. Science (1976) 1.04
A region of mouse chromosome 16 is syntenic to the DiGeorge, velocardiofacial syndrome minimal critical region. Genome Res (1997) 1.03
Cloning of cDNA for the bovine IL-2 receptor (bovine Tac antigen). Immunology (1988) 1.02
Identification of two distinct subsets of bovine gamma delta T cells with unique cell surface phenotype and tissue distribution. Immunology (1997) 1.02
Human X inactivation center induces random X chromosome inactivation in male transgenic mice. Genomics (1999) 1.01
Stability changes in pim-1 proto-oncogene mRNA after mitogen stimulation of normal lymphocytes. J Immunol (1991) 1.00
Inhibition of T-lymphocyte mitogenic responses and effects on cell functions by bovine herpesvirus 1. J Virol (1989) 0.99
Hoechst 33258, distamycin A, and high mobility group protein I (HMG-I) compete for binding to mouse satellite DNA. Chromosoma (1992) 0.98
Directional binding of HMG-I(Y) on four-way junction DNA and the molecular basis for competitive binding with HMG-1 and histone H1. Nucleic Acids Res (1999) 0.98
Differential in vivo modifications of the HMGI(Y) nonhistone chromatin proteins modulate nucleosome and DNA interactions. Biochemistry (2000) 0.97
Persistent infection of rabbits with bovine leukemia virus associated with development of immune dysfunction. J Virol (1989) 0.97
Carbohydrate modifications of the high mobility group proteins. Proc Natl Acad Sci U S A (1981) 0.96
Structure of Xenopus ribosomal gene chromatin during changes in genomic transcription rates. Cold Spring Harb Symp Quant Biol (1978) 0.96
www.elearnSCI.org: a global educational initiative of ISCoS. Spinal Cord (2013) 0.96
Sequence and analysis of the murine Hmgiy (Hmga1) gene locus. Gene (2001) 0.95
High mobility group-I(Y) protein facilitates nuclear factor-kappaB binding and transactivation of the inducible nitric-oxide synthase promoter/enhancer. J Biol Chem (1999) 0.95
Nucleosome structure of Xenopus oocyte amplified ribosomal genes. Biochemistry (1978) 0.94
Base-pair substitutions in avian sarcoma virus U5 and U3 long terminal repeat sequences alter the process of DNA integration in vitro. J Virol (2001) 0.94
High-mobility-group protein I can modulate binding of transcription factors to the U5 region of the human immunodeficiency virus type 1 proviral promoter. J Virol (2000) 0.93
Production and characterization of biologically active human GM-CSF secreted by genetically modified plant cells. Protein Expr Purif (2000) 0.93
Xrep, a plasmid-stimulating X chromosomal sequence bearing similarities to the BK virus replication origin and viral enhancers. Nucleic Acids Res (1986) 0.92
HMGI(Y) activation by chromosome 6p21 rearrangements in multilineage mesenchymal cells from pulmonary hamartoma. Am J Pathol (1997) 0.91
Silencer activity in the interferon-A gene promoters. J Biol Chem (1997) 0.91
Microheterogeneity of the mammalian high mobility group (HMG) proteins 1 and 2 investigated by reverse-phase high performance liquid chromatography. Anal Biochem (1985) 0.91
Characterization of the testes-specific pim-1 transcript in rat. Nucleic Acids Res (1992) 0.90
Induction of high mobility group-I(Y) protein by endotoxin and interleukin-1beta in vascular smooth muscle cells. Role in activation of inducible nitric oxide synthase. J Biol Chem (1999) 0.90
Large granular lymphocytes from SCID horses develop potent cytotoxic activity after treatment with human recombinant interleukin 2. J Immunol (1987) 0.90
Recombination of exogenous interleukin 2 receptor gene flanked by immunoglobulin recombination signal sequences in a pre-B cell line and transgenic mice. J Biol Chem (1991) 0.89
Expression and characterization of the interleukin 2 receptor in Theileria parva-infected bovine lymphocytes. Eur J Immunol (1989) 0.89
The non-histone chromosomal protein HMG-I(Y) contributes to repression of the immunoglobulin heavy chain germ-line epsilon RNA promoter. Eur J Immunol (1995) 0.89
Microheterogeneity of the mammalian high-mobility group proteins 14 and 17 investigated by reverse-phase high-performance liquid chromatography. Anal Biochem (1985) 0.88
Reactive oxygen and nitrogen intermediates and products from polyamine degradation are Babesiacidal in vitro. Ann N Y Acad Sci (1996) 0.88
Tumor promoter induces high mobility group HMG-Y protein expression in transformation-sensitive but not -resistant cells. Oncogene (1998) 0.88
Characterization of the proto-oncogene pim-1: kinase activity and substrate recognition sequence. Arch Biochem Biophys (1992) 0.87
Investigations of the possible functions for glycosylation in the high mobility group proteins. Evidence for a role in nuclear matrix association. J Biol Chem (1983) 0.87
The relationship of bacterial penetration and pulpal pathosis in carious teeth. Oral Surg Oral Med Oral Pathol (1966) 0.86
Effects of epidermal growth factor and estrogen on the regulation of the HMG-I/Y gene in human mammary epithelial cell lines. DNA Cell Biol (1997) 0.86
Partial inhibition of histone deacetylase in active chromatin by HMG 14 and HMG 17. Nucleic Acids Res (1980) 0.86
Differential regulation of a multipromoter gene. Selective 12-O-tetradecanoylphorbol-13-acetate induction of a single transcription start site in the HMG-I/Y gene. J Biol Chem (1995) 0.86
Bovine leukemia virus transmembrane protein gp30 physically associates with the down-regulatory phosphatase SHP-1. Cell Immunol (1999) 0.85
Replacement of conserved threonines by alanine residues in high mobility group protein HMG-I(Y): effect on DNA binding affinity. Biochem Biophys Res Commun (1995) 0.84
Use of YAC fragmentation to delimit a duplicated region on human chromosome 21. Mamm Genome (1996) 0.84
Factors affecting the permissiveness of porcine alveolar macrophages for porcine reproductive and respiratory syndrome virus. Arch Virol (2008) 0.84
Immunologic reconstitution of foals with combined immunodeficiency. Vet Immunol Immunopathol (1987) 0.84
Analysis and reconstruction of Xenopus ribosomal chromatin nucleosomes. Eur J Biochem (1977) 0.84
The long-term antihypertensive activity and tolerability of irbesartan with hydrochlorothiazide. J Hum Hypertens (1999) 0.84
Isolation and mapping of four new DNA markers from mouse chromosome 4. Mamm Genome (1992) 0.84
Polarization observations with the Cosmic Background Imager. Science (2004) 0.84
Cumulative hazard analysis of J-wire fracture in the Accufix series of atrial permanent pacemaker leads. Pacing Clin Electrophysiol (1998) 0.83
In vivo incorporation of Drosophila H2a histone into mammalian chromatin. Nucleic Acids Res (1983) 0.83